quinapril has been researched along with Diabetic Angiopathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, TJ; Cooper, ME; de Gasparo, M; Feng, B; Jandeleit-Dahm, KA; Li, J; Schumacher, C; Thomas, MC; Watson, AM | 1 |
| Guven, O; Guzelsoy, D; Sipahi, I; Tekin, G; Yigit, Z | 1 |
| Dominguez, H; Hansen, KW; Hawkins, M; Hermann, TS; Ihlemann, N; Kober, L; Li, W; Major-Pedersen, A; Nielsen, DB; Rask-Madsen, C; Torp-Pedersen, C | 1 |
| Donker, AJ; Lambert, J; Schalkwijk, CG; Smulders, RA; Stehouwer, CD | 1 |
2 trial(s) available for quinapril and Diabetic Angiopathies
| Article | Year |
|---|---|
Quinapril treatment increases insulin-stimulated endothelial function and adiponectin gene expression in patients with type 2 diabetes.
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Base Sequence; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; DNA Primers; Endothelium, Vascular; Female; Gene Expression Regulation; Heart Rate; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Polymerase Chain Reaction; Quinapril; Tetrahydroisoquinolines | 2006 |
ACE-inhibition modulates some endothelial functions in healthy subjects and in normotensive type 1 diabetic patients.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Brachial Artery; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Double-Blind Method; E-Selectin; Endothelins; Endothelium, Vascular; Female; Humans; Isoquinolines; Male; Plasminogen Activator Inhibitor 1; Quinapril; Tetrahydroisoquinolines; Tissue Plasminogen Activator; Vascular Cell Adhesion Molecule-1; Vasodilation; von Willebrand Factor | 2000 |
2 other study(ies) available for quinapril and Diabetic Angiopathies
| Article | Year |
|---|---|
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.
Topics: Animals; Antihypertensive Agents; Apolipoproteins E; Atherosclerosis; Blood Pressure; Diabetic Angiopathies; Diabetic Nephropathies; Disease Models, Animal; Endothelin Receptor Antagonists; Hyperglycemia; Hyperlipidemias; Kidney; Kidney Function Tests; Mice; Mice, Knockout; Pyridines; Pyrimidines; Quinapril; Tetrahydroisoquinolines | 2010 |
Effect of quinapril on the attenuated heart rate recovery of type 2 diabetic subjects without known coronary artery disease.
Topics: Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Case-Control Studies; Coronary Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart Rate; Humans; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 2004 |